Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
83 /100
CRITICAL RISK
Score updated Aug 28, 2026

OTLK — Outlook Therapeutics, Inc. Dilution Risk Tracker

Track OTLK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OTLK — Get alerts when the score changes →

As of August 28, 2026, Outlook Therapeutics, Inc. (OTLK) has a DilutionWatch DilutionScore of 83/100, rated CRITICAL dilution risk. Outlook Therapeutics, Inc. has a market capitalization of $108.47M, 120.86M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $5.00M, 40.35M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 67%
💰 Capital Raise model 73%
• Critical: only 1.9 months cash remaining
• Active ATM program with $5M remaining capacity
🔄 Reverse Split model est. 70%
• 50-day avg $0.28 below $1 exchange minimum
• Only 2 months cash — financial pressure
📜 Warrant Exercise model 50%
• Massive warrant overhang: 33% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track OTLK — Get forecast alerts →

Market Data

Market Cap$108.47M
Shares Outstanding120.86M
Float105.53M
Cash$7.75M
Debt$544.97M
Short InterestN/A

Institutional Holdings

10 institutional holders · 7.12M shares
#1 Schonfeld Strategic Advisors Llc 2.44M shares
#2 Vanguard Capital Management LLC 1.97M shares
#3 Gilpin Wealth Management, LLC 600.2K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest20.01M
Days to Cover1.1
% of Float19.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2025-09-30
Form 4 INSIDER TRANSACTION 2026-08-12
424B5 ATM 2026-04-23
8-K 8K EVENT 2026-04-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual OTLK Dilution Snapshot

Outlook Therapeutics, Inc. (OTLK) has a DilutionScore of 83/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track OTLK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OTLK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OTLK
OTLK FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.